Literature DB >> 33535454

Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes.

Ria Park1, Eun Jeong Park1, Yong-Yeon Cho1, Joo Young Lee1, Han Chang Kang1, Im-Sook Song2, Hye Suk Lee1.   

Abstract

Eudesmin, fargesin, epimagnolin A, magnolin, and yangambin are tetrahydrofurofuranoid lignans with various pharmacological activities found in Magnoliae Flos. The inhibition potencies of eudesmin, fargesin, epimagnolin A, magnolin, and yangambin on six major human uridine 5'-diphospho-glucuronosyltransferase (UGT) activities in human liver microsomes were evaluated using liquid chromatography-tandem mass spectrometry and cocktail substrates. Eudesmin, fargesin, epimagnolin A, magnolin, and yangambin inhibited UGT1A1 and UGT1A3 activities, but showed negligible inhibition of UGT1A4, UGT16, UGT1A9, and UGT2B7 activities at 200 μM in pooled human liver microsomes. Moreover, eudesmin, fargesin, epimagnolin A, magnolin, and yangambin noncompetitively inhibited UGT1A1-catalyzed SN38 glucuronidation with Ki values of 25.7, 25.3, 3.6, 26.0, and 17.1 μM, respectively, based on kinetic analysis of UGT1A1 inhibition in pooled human liver microsomes. Conversely, the aforementioned tetrahydrofurofuranoid lignans competitively inhibited UGT1A3-catalyzed chenodeoxycholic acid 24-acyl-glucuronidation with 39.8, 24.3, 15.1, 37.6, and 66.8 μM, respectively in pooled human liver microsomes. These in vitro results suggest the necessity of evaluating whether the five tetrahydrofurofuranoid lignans can cause drug-drug interactions with UGT1A1 and UGT1A3 substrates in vivo.

Entities:  

Keywords:  UDP-glucuronosyltransferase; epimagnolin A; eudesmin; fargesin; human liver microsomes; magnolin; yangambin

Year:  2021        PMID: 33535454      PMCID: PMC7912740          DOI: 10.3390/pharmaceutics13020187

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  43 in total

1.  Antihypertensive effects of fargesin in vitro and in vivo via attenuating oxidative stress and promoting nitric oxide release.

Authors:  Sha Sha; Dandan Xu; Yanwei Wang; Weifang Zhao; Xiaoni Li
Journal:  Can J Physiol Pharmacol       Date:  2016-04-19       Impact factor: 2.273

2.  Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.

Authors:  Xin Wang; Yongjie Cheng; Hui Xue; Yuan Yue; Weifang Zhang; Xiaoni Li
Journal:  Fitoterapia       Date:  2015-05-27       Impact factor: 2.882

3.  In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes.

Authors:  Dong Kyun Kim; Kwang-Hyeon Liu; Ji Hyun Jeong; Hye Young Ji; Sei-Ryang Oh; Hyeong-Kyu Lee; Hye Suk Lee
Journal:  Xenobiotica       Date:  2011-02-04       Impact factor: 1.908

4.  Pharmacokinetics of magnolin in rats.

Authors:  Nam Jin Kim; Won Young Song; Sun Dong Yoo; Sei-Ryang Oh; Hyeong-Kyu Lee; Hye Suk Lee
Journal:  Arch Pharm Res       Date:  2010-07-06       Impact factor: 4.946

5.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

6.  Simultaneous determination of magnolin and epimagnolin A in rat plasma by liquid chromatography with tandem mass spectrometry: Application to pharmacokinetic study of a purified extract of the dried flower buds of Magnolia fargesii, NDC-052 in rats.

Authors:  Nam Jin Kim; Sei-Ryang Oh; Hyung Kyu Lee; Hye Suk Lee
Journal:  J Pharm Biomed Anal       Date:  2009-04-07       Impact factor: 3.935

7.  Quantitative and structural analysis of amides and lignans in Zanthoxylum armatum by UPLC-DAD-ESI-QTOF-MS/MS.

Authors:  Vishal Kumar; Shiv Kumar; Bikram Singh; Neeraj Kumar
Journal:  J Pharm Biomed Anal       Date:  2014-01-30       Impact factor: 3.935

8.  Herb-drug interactions: systematic review, mechanisms, and therapies.

Authors:  Zhong Zuo; Min Huang; Isadore Kanfer; Moses S S Chow; William C S Cho
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

9.  Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.

Authors:  Cheol-Jung Lee; Mee-Hyun Lee; Sun-Mi Yoo; Kyung-Il Choi; Ji-Hong Song; Jeong-Hoon Jang; Sei-Ryang Oh; Hyung-Won Ryu; Hye-Suk Lee; Young-Joon Surh; Yong-Yeon Cho
Journal:  BMC Cancer       Date:  2015-08-08       Impact factor: 4.430

10.  Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

Authors:  Soon-Sang Kwon; Ju-Hyun Kim; Hyeon-Uk Jeong; Yong Yeon Cho; Sei-Ryang Oh; Hye Suk Lee
Journal:  Molecules       Date:  2016-04-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.